Get the Stockscreener App
24.60
0.10%
0.04
Ishares Genomics Immunology And Healthcare Etf stock is traded at $24.60, with a volume of 62,696.
It is up +0.10% in the last 24 hours and up +0.10% over the past month.
See More
Previous Close:
$24.56
Open:
$24.53
24h Volume:
62,696
Relative Volume:
2.41
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.54%
1M Performance:
+0.10%
6M Performance:
+3.04%
1Y Performance:
+26.34%
1-Day Range:
$24.21
$24.60
1-Week Range:
$24.06
$24.68
52-Week Range:
$17.95
$25.70
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Name
Ishares Genomics Immunology And Healthcare Etf
Sector
Industry
Phone
-
Address
-
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Latest News
7 Best-Performing Biotech ETFs for October 2024 - NerdWallet
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) Quotes, Forecast and News Summary - Benzinga
iShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1114 - MSN
7 Best Biotech ETFs In Canada for September 2024 - Wealth Awesome
BlackRock® Canada Announces June Cash Distributions for the iShares® ETFs - Yahoo Finance
Moderna ETFs to Rally on Positive COVID-19 Booster Shot News - Yahoo News UK
IDNA ETF: Healthcare Dashboard For February - Seeking Alpha
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Finance
Has Biotechnology Bottomed Out? - Master Investor
2024 Market Forecast: 3 Key Trends in the Healthcare Industry - InvestorPlace
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
Which Pharma Stocks Are Relying on Immunology for Future Growth? - Opto RoW
IDNA: Continues To Underperform, But With Long-Term Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - U.S News & World Report Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
Noticeable performance for Healthcare and Biotech ETFs - Trackinsight
Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility - Investing.com India
Vir Jumps 20% On S&P SmallCap 600 News - Yahoo Finance
Let's Check Up on 2 Immunology-Focused Oncology ETFs - TheStreet
ETF Battles: ARKG Vs IDNA Vs GNOM - Yahoo Finance
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
Go Beyond Trends: Healthcare Megatrends and IDNA - ETFdb.com
Why You Should Invest in Genomics ETFs - Yahoo Movies Canada
Invest in the Future With Megatrend ETFs - Yahoo Canada Shine On
Genomics ETFs Surge on CRISPR's Gene Editing Progress - Zacks Investment Research
Why megatrend ETFs offer long-term growth potential - ETF Strategy
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Launches Megatrend ETF Suite Designed to Capture Five Transformational Long-Term Trends - Business Wire
ARK Genomic Revolution ETF - ETFdb.com
Editas Medicine (EDIT) Stock Price, News & Analysis - MarketBeat
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Financials Data
There is no financial data for Ishares Genomics Immunology And Healthcare Etf (IDNA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):